Lombardy Region has issued a new call for tender enabling the creation of a “non-invasive and innovative solution for the assessment of coronary atherosclerotic plaque fragility

The path set up by Lombardy Region on the basis of ERDF ROP 2014-2020 is continuing through the Pre-Commercial Procurement – PCP innovative tool. First of all, the public entity has identified the innovation needs – the so-called “technological needs” – arising from physicians and patients by precisely collecting the existing needs, has approved them during the Regional Council’s meeting which took place on December,28 2017 and has issued the first two calls for tenders. Now Lombardy Region launched the third procedure enabling the creation of a “non-invasive and innovative solution for the assessment of coronary atherosclerotic plaque fragility”. This technology, indeed, isn’t still available on the market, and Lombardy Region aims at financing its concept and realization.

The public administration will finance the research, the development and the experimentation phases required to implement the technologies aimed at satisfying the need of Azienda Socio-Sanitaria Territoriale (ASST) of Pavia described in the pre-commercial procurement. The peculiarity of this tool consists in its formulation, specifically, Lombardy Region will not require the winning bidders to provide goods or services already available on the market but rather research and development services related to new innovative solution (belonging to the healthcare industry) on the basis of the suggestions that experts have previously provided to the public entity.


The process has begun with a precise analysis of the healthcare needs and with the validation of the requirement necessary for launching a pre-commercial procurement call for tender. The demand analysis started with a public invitation addressed to Lombardy public and private ASST, IRCCS and private nursing houses, and has highlighted the elements based on which the calls for tenders have been issued. Specifically, the entities and the medical staff have described those patients’ needs that are not satisfied by the state-of-the-art procedures and the technologies. Therefore, Lombardy Region, after having found out the unavailability on the market of the above-mentioned technologies, has decided to issue the calls for tenders aiming at developing innovative solutions able to solve these technologically complex problems and opening new markets.


ASST of Pavia, proposer of the innovation need, has launched the tender and operates as the Contracting Authority for the completion of the pre-commercial procurement procedure.

The problem highlighted concerns the fact that, even with the modern technology, it is not possible to prevent the onset of acute myocardial infarction, one of the main causes of death in the developed countries, due in many cases to an acute coronary artery occlusion for the formation of a thrombus on an ulcerated atherosclerotic lesion. The identification of vulnerable atherosclerotic plaque could represent a parameter which identify high risk patients.

This parameter will be used in any cardiology department to identify patients at high risk of myocardial infarction: this identification would lead to clear benefit to the patients with early diagnosis and reduction of the cost for the national health service in terms of use of implantable devices (CND J). The parameter could be also useful in neurology or vascular surgery department as well.

The multi-stage bidding procedure with multiple bidders award provides that the R&D services will last 28 months. The value of the tender amounts to euro 2.460.655,7 (excluded VAT). The opening bid for the procedure’s first stage (STEP 1), relative to the design of the Innovative Solution subject matter of the tendering, amounts, for each bidder, to euro 98.360,65 (excluded VAT).

The deadline for submitting bids is 31/08/2018, at 16.00 local time.

Further information are available at the following link:


As an innovative tool, the pre-commercial procurement has been promoted by the regional law 29/2016 “Lombardia è ricerca e innovazione”. It provides for a multiple bidders award and multiple stages procedure, assuming that the need for which the call for tender has been issued cannot be satisfied by solutions already available on the market. The public entity shares with the winning bidders risks and benefits of the research and development activities at market conditions. However, the advantage for the public entity consists in having the possibility of comparing and testing different technological alternatives before proceeding with a new public procurement call for tender.


The call for tenders enables a competition among the best international players of the industry. The Regional Council gave green light to the project with the resolution n. 6582 of May, 12 2017. After accomplishing the different steps required by the law for this kind of procedure, on October, 12 2017, while Lombardy Region was also verifying the existing patents, the market consultation, for illustrating the gathered medical needs, was open. Lastly, on December, 28 2017, the Regional Council has approved the validation of all the needs, giving therefore the green light for issuing the call for tenders.

go to top